Pyrrolidine → N-(5-methylpyrazin-2-yl)-6-{[5-(2-pyrrolidin-1-ylethoxy)pyridin-2-yl]oxy}quinazoline-4-amine

HRID 81652

Reaktionsgleichung

Reaktionsgleichung von HRID 81652
[CH3:1][C:2]1[N:3]=[CH:4][C:5]([NH:8][C:9]2[C:18]3[C:13](=[CH:14][CH:15]=[C:16]([OH:19])[CH:17]=3)[N:12]=[CH:11][N:10]=2)=[N:6][CH:7]=1.C(O[CH:23](OCC)[CH2:24][O:25][C:26]1[CH:27]=[CH:28][C:29](F)=[N:30][CH:31]=1)C.[NH:36]1[CH2:40][CH2:39][CH2:38][CH2:37]1>>[CH3:1][C:2]1[N:3]=[CH:4][C:5]([NH:8][C:9]2[C:18]3[C:13](=[CH:14][CH:15]=[C:16]([O:19][C:29]4[CH:28]=[CH:27][C:26]([O:25][CH2:24][CH2:23][N:36]5[CH2:40][CH2:39][CH2:38][CH2:37]5)=[CH:31][N:30]=4)[CH:17]=3)[N:12]=[CH:11][N:10]=2)=[N:6][CH:7]=1

Komponenten

4

Edukt 3

HCID 31268PyrrolidineHCID 684297065-(2,2-Diethoxyethoxy)-2-fluoropyridineHCID 1356182224-((5-Methylpyrazin-2-yl)amino)quinazolin-6-ol

Produkt 1

HCID 59508903N-(5-methylpyrazin-2-yl)-6-{[5-(2-pyrrolidin-1-ylethoxy)pyridin-2-yl]oxy}quinazoline-4-amine

Versuchsvorschrift

The compound of Example 38 was obtained as follows: Using 4-[(5-methylpyrazin-2-yl)amino]quinazolin-6-ol, 5-(2,2-diethoxyethoxy)-2-fluoropyridine and pyrrolidine, and in the same manner as in Example 31 or according to a method similar to it or according to a combination thereof with an ordinary method, the entitled compound (11 mg) was obtained as a pale yellow solid.

Quellen und Nachweise

ORD-Eintrag
ord-3a720d1569874d5f8b81c2a6d3cc46f3
Quelldatensatz
uspto-grants-2014_09
Patentnummer
US08846700B2

Verknüpfte Notizen

Wird geladen…